Hair repigmentation associated with thalidomide use for the treatment of multiple myeloma
Authors:
- 21 July 2016
- journal article
- case report
- Published by BMJ in BMJ Case Reports
- Vol. 2016
Abstract
A 75-year-old woman diagnosed with multiple myeloma in 2007 began treatment with monthly melphalan and prednisone for a total of 9 cycles in combination with thalidomide in 2009. The patient subsequently continued on thalidomide for long-term maintenance therapy. 3 years following initiation of thalidomide, the patient mentioned to her oncologist that her hair had become darker over the years. She attributed the change to thalidomide given the temporal relationship and progressive darkening over the course of therapy. The patient denies ever using any hair colouring treatments and had longstanding grey/white hair before beginning thalidomide in 2009. A case of hair repigmentation associated with the use of lenalidomide, a 4-amino-glutamyl analogue of thalidomide, in a patient with multiple myeloma was previously reported in the literature. We report herein the first case of hair repigmentation associated with the use of thalidomide, a related immunomodulatory drug.Keywords
This publication has 13 references indexed in Scilit:
- Repigmentation of hair following adalimumab therapyDermatology Online Journal, 2015
- Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process!Journal of Oncology Pharmacy Practice, 2012
- Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from 6 randomized clinical trialsBlood, 2011
- Anti-fibrotic effect of thalidomide through inhibiting TGF-β-induced ERK1/2 pathways in bleomycin-induced lung fibrosis in miceInflammation Research, 2009
- Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair PigmentationThe Journal of Clinical Endocrinology & Metabolism, 2008
- Thalidomide: Mechanisms of ActionInternational Reviews of Immunology, 2008
- Repigmentation of Gray Hair After Thyroid Hormone TreatmentActas Dermo-Sifiliograficas, 2007
- Hair Follicle PigmentationJournal of Investigative Dermatology, 2005
- The clinical and biological effects of thalidomide in patients with myelodysplastic syndromesBritish Journal of Haematology, 2001
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981